Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 16S ribosomal RNA (rRNA) decoding A-site is a critical functional region within the 30S small ribosomal subunit responsible for ensuring the fidelity of protein synthesis [PubMed: 11586302]. During translation, this site monitors the base-pairing between the mRNA codon and the aminoacyl-tRNA anticodon [PubMed: 10993070]. When a correct match occurs, specific adenine residues, A1492 and A1493, flip out of the internal loop of helix 44 to stabilize the interaction, signaling the ribosome to proceed with peptide bond formation [PubMed: 11012830]. This site is the primary therapeutic target for aminoglycoside antibiotics, such as gentamicin and amikacin, which bind to the internal loop and lock these adenine residues in the 'active' conformation [PubMed: 15916402]. This drug-induced conformational change causes the ribosome to accept near-cognate tRNAs, leading to the production of mistranslated, dysfunctional proteins that compromise bacterial cell membrane integrity [PubMed: 17626568]. Additionally, some drugs like tetracyclines bind to the 16S rRNA in the A-site to physically block the docking of aminoacyl-tRNA, thereby inhibiting protein synthesis [PubMed: 11130708]. Because the bacterial A-site structure is distinct from the human cytosolic ribosome, it allows for selective toxicity, although similarities with human mitochondrial 12S rRNA can lead to adverse effects like ototoxicity [PubMed: 12657573]. Resistance to drugs targeting this site often arises through enzymatic modification of the drugs or methylation of the 16S rRNA by specialized methyltransferases [PubMed: 17307851].
Aminoglycosides bind to the 16S rRNA A-site, inducing a conformational change in residues A1492 and A1493 that mimics cognate tRNA binding, leading to mistranslation and membrane damage; Tetracyclines bind to the A-site to sterically block aminoacyl-tRNA attachment, inhibiting protein synthesis.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 16S ribosomal RNA decoding A-site (16S rRNA A-site) (16S rRNA A-site).